• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左氧氟沙星在人类软组织感染中的组织药代动力学。

Tissue pharmacokinetics of levofloxacin in human soft tissue infections.

作者信息

Bellmann Romuald, Kuchling Gerald, Dehghanyar Pejman, Zeitlinger Markus, Minar Erich, Mayer Bernhard X, Müller Markus, Joukhadar Christian

机构信息

Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, University of Vienna Medical School, Austria.

出版信息

Br J Clin Pharmacol. 2004 May;57(5):563-8. doi: 10.1111/j.1365-2125.2004.02059.x.

DOI:10.1111/j.1365-2125.2004.02059.x
PMID:15089808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1884508/
Abstract

AIMS

The present study addressed the ability of levofloxacin to penetrate into subcutaneous adipose tissues in patients with soft tissue infection.

METHODS

Tissue concentrations of levofloxacin in inflamed and healthy subcutaneous adipose tissue were measured in six patients by microdialysis after administration of a single intravenous dose of 500 mg. Levofloxacin was assayed by high-performance liquid chromatography.

RESULTS

The mean concentration vs time profile of free levofloxacin in plasma was identical to that in inflamed and healthy tissues. The ratios of the mean area under the free levofloxacin concentration vs time curve from 0 to 10 h (AUC(0,10 h)) in tissue to that in plasma were 1.2 +/- 1.0 for inflamed and 1.1 +/- 0.6 for healthy subcutaneous adipose tissue (mean +/- SD). The mean difference in the ratio of the AUC(tissue) : AUC(plasma) for inflamed and healthy tissue was 0.09 (95% confidence interval -0.58, 0.759, P > 0.05). Interindividual variability in tissue penetration was high, as indicated by a coefficient of variation of approximately 82% for AUC(tissue) : AUC(plasma) ratios.

CONCLUSIONS

The penetration of levofloxacin into tissue appears to be unaffected by local inflammation. Our plasma and tissue data suggest that an intravenous dose of 500 mg levofloxacin provides effective antibacterial concentrations at the target site. However, in treatment resistant patients, tissue concentrations may be sub-therapeutic.

摘要

目的

本研究探讨左氧氟沙星在软组织感染患者中渗透至皮下脂肪组织的能力。

方法

对6例患者单次静脉注射500mg左氧氟沙星后,采用微透析法测定左氧氟沙星在炎症及健康皮下脂肪组织中的浓度。采用高效液相色谱法测定左氧氟沙星含量。

结果

血浆中游离左氧氟沙星的平均浓度-时间曲线与炎症及健康组织中的曲线相同。炎症皮下脂肪组织中游离左氧氟沙星浓度-时间曲线从0至10小时的平均曲线下面积(AUC(0,10 h))与血浆中该曲线下面积的比值为1.2±1.0,健康皮下脂肪组织为1.1±0.6(均值±标准差)。炎症组织与健康组织的AUC(组织) : AUC(血浆)比值的平均差异为0.09(95%置信区间-0.58,0.759,P>0.05)。AUC(组织) : AUC(血浆)比值的变异系数约为82%,表明组织渗透的个体间变异性较高。

结论

左氧氟沙星向组织中的渗透似乎不受局部炎症影响。我们的血浆和组织数据表明,静脉注射500mg左氧氟沙星可在靶部位提供有效的抗菌浓度。然而,对于治疗抵抗的患者,组织浓度可能低于治疗水平。

相似文献

1
Tissue pharmacokinetics of levofloxacin in human soft tissue infections.左氧氟沙星在人类软组织感染中的组织药代动力学。
Br J Clin Pharmacol. 2004 May;57(5):563-8. doi: 10.1111/j.1365-2125.2004.02059.x.
2
A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung.一项初步研究,旨在测试软组织间质液中左氧氟沙星的浓度是否可作为预测其在肺部药代动力学的替代指标。
Int J Antimicrob Agents. 2007 Jan;29(1):44-50. doi: 10.1016/j.ijantimicag.2006.08.045.
3
In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery.心脏手术后左氧氟沙星在肺组织中的体内渗透测量。
Antimicrob Agents Chemother. 2005 Dec;49(12):5107-11. doi: 10.1128/AAC.49.12.5107-5111.2005.
4
Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.利奈唑胺在糖尿病软组织感染患者单剂量和多剂量给药后的靶位药代动力学
J Clin Pharmacol. 2014 Sep;54(9):1058-62. doi: 10.1002/jcph.296. Epub 2014 May 20.
5
Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans.莫西沙星在人体健康及炎症状态下皮下脂肪组织中的渗透情况。
Antimicrob Agents Chemother. 2003 Oct;47(10):3099-103. doi: 10.1128/AAC.47.10.3099-3103.2003.
6
Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.单次口服剂量的环丙沙星缓释片(1000毫克)与左氧氟沙星(500毫克)在健康男女志愿者血浆和尿液中的药代动力学研究。
Int J Antimicrob Agents. 2006 Jan;27(1):7-14. doi: 10.1016/j.ijantimicag.2005.09.014. Epub 2005 Dec 15.
7
Diffusion of levofloxacin into bone and synovial tissues.左氧氟沙星在骨组织和滑膜组织中的扩散。
J Antimicrob Chemother. 2004 Mar;53(3):533-5. doi: 10.1093/jac/dkh110. Epub 2004 Feb 12.
8
Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers.健康志愿者中多次静脉注射750毫克左氧氟沙星的安全性和药代动力学。
Antimicrob Agents Chemother. 2001 Jul;45(7):2122-5. doi: 10.1128/AAC.45.7.2122-2125.2001.
9
Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections.达托霉素对糖尿病合并细菌性足部感染患者软组织和骨组织的穿透能力。
J Antimicrob Chemother. 2010 Jun;65(6):1252-7. doi: 10.1093/jac/dkq109. Epub 2010 Apr 7.
10
Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis.左氧氟沙星对软组织的穿透性与脓毒症患者靶位细菌清除的相关性
Antimicrob Agents Chemother. 2003 Nov;47(11):3548-53. doi: 10.1128/AAC.47.11.3548-3553.2003.

引用本文的文献

1
Intrauterine infusion of autologous platelet-rich plasma modulates endometrial immune status and improves pregnancy outcomes in patients with persistent chronic endometritis.宫腔内输注自体富血小板血浆可调节子宫内膜免疫状态并改善持续性慢性子宫内膜炎患者的妊娠结局。
Front Immunol. 2025 May 15;16:1528522. doi: 10.3389/fimmu.2025.1528522. eCollection 2025.
2
Dynamic distribution of systemically administered antibiotics in orthopeadically relevant target tissues and settings.系统给予的抗生素在骨科相关靶组织和环境中的动态分布。
APMIS. 2024 Dec;132(12):992-1025. doi: 10.1111/apm.13490. Epub 2024 Nov 12.
3
Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults.抗生素在皮下和肌肉间隙液中的渗透:成人微量透析研究的荟萃分析。
Clin Pharmacokinet. 2024 Jul;63(7):965-980. doi: 10.1007/s40262-024-01394-z. Epub 2024 Jul 2.
4
Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Reponse Exemplified by Levofloxacin.哪种分析方法适合利用临床微透析数据?以左氧氟沙星为例的暴露和反应研究的定量比较。
Pharm Res. 2021 Mar;38(3):381-395. doi: 10.1007/s11095-021-02994-1. Epub 2021 Mar 15.
5
Formulation and evaluation of simvastatin polymeric nanoparticles loaded in hydrogel for optimum wound healing purpose.用于最佳伤口愈合目的的载于水凝胶中的辛伐他汀聚合物纳米粒的制备与评价
Drug Des Devel Ther. 2019 May 10;13:1567-1580. doi: 10.2147/DDDT.S198413. eCollection 2019.
6
Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens.多利培南在血浆和上皮衬液(ELF)中的药代动力学:两种给药方案的比较。
Eur J Clin Pharmacol. 2017 Dec;73(12):1609-1613. doi: 10.1007/s00228-017-2327-y. Epub 2017 Sep 17.
7
A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.关于抗生素在人体组织间隙液中的药代动力学的全面综述:对给药及临床药代动力学监测的意义
Clin Pharmacokinet. 2014 Aug;53(8):695-730. doi: 10.1007/s40262-014-0152-3.
8
Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development.微透析技术评估脑癌肿瘤内药物分布:合理药物开发的工具。
Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1477-91. doi: 10.1517/17425255.2010.523420. Epub 2010 Oct 23.
9
Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modelling.利用活检数据和基于全身生理的药代动力学模型确定巨噬细胞在局部莫西沙星组织浓度中的作用。
Clin Pharmacokinet. 2009;48(3):181-7. doi: 10.2165/00003088-200948030-00004.
10
Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.利奈唑胺在糖尿病足感染中炎症性软组织的药代动力学及渗透情况
Eur J Clin Pharmacol. 2008 Nov;64(11):1093-100. doi: 10.1007/s00228-008-0531-5. Epub 2008 Jul 25.

本文引用的文献

1
Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis.左氧氟沙星对软组织的穿透性与脓毒症患者靶位细菌清除的相关性
Antimicrob Agents Chemother. 2003 Nov;47(11):3548-53. doi: 10.1128/AAC.47.11.3548-3553.2003.
2
Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans.莫西沙星在人体健康及炎症状态下皮下脂肪组织中的渗透情况。
Antimicrob Agents Chemother. 2003 Oct;47(10):3099-103. doi: 10.1128/AAC.47.10.3099-3103.2003.
3
Target site penetration of fosfomycin in critically ill patients.磷霉素在重症患者中的靶位穿透情况。
J Antimicrob Chemother. 2003 May;51(5):1247-52. doi: 10.1093/jac/dkg187. Epub 2003 Mar 28.
4
Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome.磷霉素在蜂窝织炎或糖尿病足综合征患者炎症病灶中的渗透情况。
Antimicrob Agents Chemother. 2003 Jan;47(1):371-4. doi: 10.1128/AAC.47.1.371-374.2003.
5
Clinical role of protein binding of quinolones.喹诺酮类药物蛋白结合的临床作用。
Clin Pharmacokinet. 2002;41(10):741-50. doi: 10.2165/00003088-200241100-00004.
6
Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis.头孢匹罗在脓毒症患者中的血浆和组织药代动力学
Crit Care Med. 2002 Jul;30(7):1478-82. doi: 10.1097/00003246-200207000-00013.
7
Tissue distribution of imipenem in critically ill patients.亚胺培南在重症患者中的组织分布。
Clin Pharmacol Ther. 2002 May;71(5):325-33. doi: 10.1067/mcp.2002.122526.
8
Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses.每日一次口服多剂750毫克左氧氟沙星后其在皮肤组织中的渗透情况。
J Clin Pharm Ther. 2002 Apr;27(2):143-50. doi: 10.1046/j.1365-2710.2002.00396.x.
9
Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease.
Clin Pharmacol Ther. 2001 Dec;70(6):532-9. doi: 10.1067/mcp.2001.120762.
10
Microdialysis. A novel tool for clinical studies of anti-infective agents.微透析:抗感染药物临床研究的一种新型工具。
Eur J Clin Pharmacol. 2001 Jun;57(3):211-9. doi: 10.1007/s002280100301.